Sensoriumlab Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Sensoriumlab Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Wireless Telecommunications Carriers (except Satellite) | All Other Information Services | Specialized Design Services | Computer Systems Design and Related Services | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services

Full name: Sensoriumlab Sp. z o.o.

Profile Updated: May 24, 2024

SensoriumLab is a company that develops user-friendly and non-invasive diagnostic systems for assessment of pleural effusion and breast fluid diagnosis. Their main product is a pocket device called Plefind and PLeural EFussion INDicator for non-invasive monitoring of fluid in the chest. SensoriumLab is also working on optimizing the measurement process for a broader group of patients. They use various security measures to protect personal data and work with third-party partners for analytics and advertising services.

Headquarters
Ul. Williama Heerleina Lindleya 16
Warsaw; Mazowieckie; Postal Code: 02-013

Contact Details: Purchase the Sensoriumlab Sp. z o.o. report to view the information.

Website: http://www.sensoriumlab.com

Basic Information

Total Employees:

Purchase the Sensoriumlab Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Sensoriumlab Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Sensoriumlab Sp. z o.o. report to view the information.

Incorporation Date:

January 11, 2017

Key Executives

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

No results were found for this company.